TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Earnings & Estimates
NASDAQ:TNXP - US8902608392 - Common Stock
34.59 USD
-3.39 (-8.93%)
34.33 USD
-0.26 (-0.75%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.768M | 10.094M 29.94% | 12.233M 21.19% | 100.67M 722.94% | 134.13M 33.24% | ||
| EBITDA YoY % growth | -110.84M -20.14% | -114.089M -2.93% | -74.323M 34.86% | N/A | N/A | N/A | |
| EBIT YoY % growth | -112.09M -21.43% | -118.38M -5.61% | -77.744M 34.33% | -108.222M -39.20% | -91.494M 15.46% | -4.59M 94.98% | |
| Operating Margin | N/A | -1,523.94% | -770.20% | -884.67% | -90.89% | -3.42% | |
| EPS YoY % growth | -81,400.00 51.08% | -27,584.00 66.11% | -2,536.77 90.80% | -13.28 99.48% | -8.78 33.87% | -0.31 96.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.31 85.61% | -3.72 61.89% | -2.20 22.42% | -1.07 72.25% | -0.92 72.27% | -0.57 84.66% |
| Revenue Q2Q % growth | 3.366M 19.28% | 3.893M 50.77% | 23.052M 849.03% | 38.556M 1,829.73% | 48.858M 1,351.52% | 59.058M 1,417.03% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -29.07M -86.90% | -35.904M -59.72% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -3.86 99.80% | -3.28 | -0.58 | -17.71% |
| Q1 2025 Q2Q % growth | -2.84 99.51% | -3.29 | 0.45 | 13.80% |
| Q4 2024 Q2Q % growth | -9.77 99.64% | -394.86 | 385.09 | 97.53% |
| Q3 2024 Q2Q % growth | -23.00 99.61% | -299.20 | 276.20 | 92.31% |
| Q2 2024 Q2Q % growth | -1,928.00 77.52% | -333.88 | -1,594.12 | -477.45% |
| Q1 2024 Q2Q % growth | -576.00 94.46% | -1,272.96 | 696.96 | 54.75% |
| Q4 2023 Q2Q % growth | -2,752.00 75.43% | -5,363.83 | 2,611.83 | 48.69% |
| Q3 2023 Q2Q % growth | -5,856.00 57.57% | -4,863.36 | -992.64 | -20.41% |
| Q2 2023 Q2Q % growth | -8,576.00 64.85% | -8,992.32 | 416.32 | 4.63% |
| Q1 2023 Q2Q % growth | -10,400.00 67.50% | -9,894.00 | -506.00 | -5.11% |
| Q4 2022 Q2Q % growth | -11,200.00 75.00% | -17,544.00 | 6,344.00 | 36.16% |
| Q3 2022 Q2Q % growth | -13,800.00 56.88% | -20,808.00 | 7,008.00 | 33.68% |
| Q2 2022 Q2Q % growth | -24,400.00 45.54% | -29,478.00 | 5,078.00 | 17.23% |
| Q1 2022 Q2Q % growth | -32,000.00 28.57% | -30,466.18 | -1,533.82 | -5.03% |
| Q4 2021 Q2Q % growth | -44,800.00 30.00% | -39,168.00 | -5,632.00 | -14.38% |
| Q3 2021 Q2Q % growth | -32,000.00 44.44% | -45,696.00 | 13,696.00 | 29.97% |
| Q2 2021 Q2Q % growth | -44,800.00 69.57% | -42,432.00 | -2,368.00 | -5.58% |
| Q1 2021 Q2Q % growth | -44,800.00 76.67% | -35,904.00 | -8,896.00 | -24.78% |
| Q4 2020 Q2Q % growth | -64,000.00 96.50% | -48,960.00 | -15,040.00 | -30.72% |
| Q3 2020 Q2Q % growth | -57,600.00 98.42% | -71,808.00 | 14,208.00 | 19.79% |
| Q2 2020 Q2Q % growth | -147,200.00 97.58% | -146,880.00 | -320.00 | -0.22% |
| Q1 2020 Q2Q % growth | -192,000.00 97.67% | -205,632.00 | 13,632.00 | 6.63% |
| Q4 2019 Q2Q % growth | -1,830,400.00 | -972,672.00 | -857,728.00 | -88.18% |
| Q3 2019 Q2Q % growth | -3,641,600.00 | -2,839,680.00 | -801,920.00 | -28.24% |
| Q2 2019 Q2Q % growth | -6,080,000.00 | -6,440,981.76 | 360,981.76 | 5.60% |
| Q1 2019 Q2Q % growth | -8,256,000.00 | -7,050,240.00 | -1,205,760.00 | -17.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.998M -9.51% | 2.482M | -484K | -19.50% |
| Q1 2025 Q2Q % growth | 2.429M -2.14% | 2.601M | -172K | -6.61% |
| Q4 2024 Q2Q % growth | 2.582M -31.68% | 3.57M | -988K | -27.68% |
| Q3 2024 Q2Q % growth | 2.822M -29.26% | 3.145M | -323K | -10.27% |
| Q2 2024 Q2Q % growth | 2.208M | 3.57M | -1.362M | -38.15% |
| Q1 2024 Q2Q % growth | 2.482M | 3.876M | -1.394M | -35.96% |
| Q4 2023 Q2Q % growth | 3.779M | 3.91M | -131K | -3.35% |
| Q3 2023 Q2Q % growth | 3.989M | 5.916M | -1.927M | -32.57% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 5.94% | 13.24% | -6.17% | 8.05% |
| Revenue | 0% | 24.53% | -1.37% | 8.05% |